NUP98::NSD1 and FLT3/ITD co-expression is an independent predictor of poor prognosis in pediatric AML patients
Abstract Objective Patients who carry NUP98::NSD1 or FLT3/ITD mutations are reported to have poor prognosis. Previous studies have confidently reported that the poor outcome in younger AML patients is owning to dual NUP98::NSD1 and FLT3/ITD positivity, with a high overlap for those two genetic lesio...
Saved in:
Main Authors: | Jing-wen Wang (Author), Yu-Li (Author), Xing-Ge Yang (Author), Lu-Hong Xu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of three pediatric AML co-expressing NUP98-NSD1, FLT3-ITD, and WT1
by: Li Liu, et al.
Published: (2024) -
Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML
by: Franziska Schmidt, et al.
Published: (2022) -
Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT3‐ITD AML
by: Daelynn R. Buelow, et al.
Published: (2019) -
Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy
by: Sankaranarayan Kannan, et al.
Published: (2022) -
Prognostic importance of NUP98-rearrangements in acute myeloid leukemia: A systematic review and meta-analysis
by: Maryam Sheikhi, et al.
Published: (2024)